Skip to content

Multidimensional Research on Addiction Intervention Based on TI Regulation: Mechanism Exploration and Efficacy Verification

Multidimensional Research on Addiction Intervention Based on TI Regulation: Mechanism Exploration and Efficacy Verification

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128961
Enrollment
Unknown
Registered
2026-07-29
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug addiction

Interventions

Group1:Theta frequency time interference stimulation targeting the nucleus accumbens under a drug cue-induced paradigm
Group2:Gamma frequency time interference stimulation targeting the nucleus accumbens under a drug cue-induced paradigm
Group3:Sham group time interference stimulation targeting the nucleus accumbensunder a drug cue-induced paradigm
Group4:Theta frequency time interference stimulation targeting the hippocampus under a drug cue-induced paradigm
Group5:Sham group time interference stimulation targeting the hippocampus under a drug cue-induced paradigm
Group6:Beta frequency time interference stimulation targeting the cerebellum under a drug cue-induced paradigm
Group7:Sham group time interference stimulation targeting the cerebellum under a drug cue-induced paradigm

Sponsors

Xidian University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Meets DSM-5 criteria for substance use disorder, aged 18-55, right-handed, of any gender, no contraindications for fMRI; voluntarily signs informed consent form

Exclusion criteria

Exclusion criteria: 1. Patients with a history of head trauma, mental retardation, mental disorders (such as epilepsy, etc.) or chronic pain diseases, and patients who cannot cooperate with examination and treatment; 2. Patients with serious primary diseases such as cancer, heart, liver, lung, kidney, hematopoietic system, etc.; 3. Pregnant or lactating women, allergies and allergies to a variety of drugs; 4. Those who are judged by the radiologist to have organic mass, bright signal or other structural abnormalities in the brain; 5. Those who may have poor compliance and those who are difficult to follow-up; 6. Claustrophobia.

Design outcomes

Primary

MeasureTime frame
Blood Oxygenation Level-Dependent signal(BOLD);

Secondary

MeasureTime frame
Electroencephalogram (EEG);Electrocardiosignal(ECG);psychological scale;

Countries

China

Contacts

Public ContactKai Yuan

Xidian University

kyuan@xidian.edu.cn+86 180 6689 8052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026